Harvard researchers developed a new blood test, HPV-DeepSeek, that can detect HPV-related head and neck cancers up to 10 years before symptoms appear. In trials, the test identified 27 of 28 future cancer cases with high accuracy. Early detection could lead to less aggressive treatments and better outcomes for patients.